{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T19:13:30Z","timestamp":1777144410909,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,30]],"date-time":"2021-10-30T00:00:00Z","timestamp":1635552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,30]],"date-time":"2021-10-30T00:00:00Z","timestamp":1635552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2020QC102"],"award-info":[{"award-number":["ZR2020QC102"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Human cytomegalovirus (HCMV) infection in utero is very common during pregnancy, which can lead to adverse outcomes in both pregnancy and progeny, but its pathogenesis has not been fully clarified. The decrease of extravillous cytotrophoblasts (EVT) invasion is an essential pathophysiological process of some pregnancy complications. Hippo-YAP signaling pathway plays an important role in regulating cell proliferation and apoptosis. However, whether YAP is involved in HCMV uterine infection remains to be studied.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The primary EVT was cultured and infected by the HCMV strain AD169 virus in vitro. Immunofluorescence staining of HCMVpp65 antigen was conducted afterward to confirm the establishment of an infection model. The optimal virus infection dose was determined by the EVT proliferation status in vitro. Real-time PCR was performed to examine the mRNA level of major genes involved in the Hippo pathway in EVT after HCMV infection. The effect of HCMV on the expression of YAP protein in EVT was evaluated by Immunofluorescence staining and Western blot. An in vitro cell invasion assay was carried out to analyze the influence of HCMV on EVT invasion. The changes of EVT invasion was accessed by establishing YAP silencing and over-expression models using YAP1 specific siRNA and plasmid pcDH.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The optimal HCMV infection dose was 282.5TCID50\/ml. Compared to the control group, the infection of HCMV significantly reduced the mRNA expression of Mst1, Mst2, SAV, Lats1, Lats2, Mob1, YAP1, TAZ, TEAD1-4 genes and YAP protein expression in the Hippo-YAP pathway. HCMV infection also decreased the EVT invasion. In non-infected EVT, the number of transmembrane EVT cells was significantly reduced when YAP1 gene was silenced, while it was significantly increased when YAP1 gene was over-expressed. In the HCMV-infected EVT, the number of transmembrane EVT cells significantly increased when over-expressed and eventually recovered to the level of NC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>HCMV may decrease EVT invasion by inhibiting the expression of mRNA and protein of YAP\u00a0in the Hippo-YAP signaling pathway. HCMV eventually reduces the invasion ability of EVT by inhibiting multiple genes in the Hippo-YAP signaling pathway, especially inhibiting YAP which serves as the downstream effector.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12985-021-01681-2","type":"journal-article","created":{"date-parts":[[2021,10,30]],"date-time":"2021-10-30T18:02:43Z","timestamp":1635616963000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Human cytomegalovirus inhibits the proliferation and invasion of extravillous cytotrophoblasts via Hippo-YAP pathway"],"prefix":"10.1186","volume":"18","author":[{"given":"Qiaoqiao","family":"Kong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cailing","family":"Bian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4295-3507","authenticated-orcid":false,"given":"Tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,30]]},"reference":[{"issue":"2","key":"1681_CR1","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.pcl.2012.12.008","volume":"60","author":"EC Swanson","year":"2013","unstructured":"Swanson EC, Schleiss MR. Congenital cytomegalovirus infection: new prospects for prevention and therapy. Pediatr Clin N Am. 2013;60(2):335\u201349.","journal-title":"Pediatr Clin N Am"},{"issue":"1","key":"1681_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s12098-009-0255-2","volume":"77","author":"P Bhatia","year":"2010","unstructured":"Bhatia P, Narang A, Minz RW. Neonatal cytomegalovirus infection: diagnostic modalities available for early disease detection. Indian J Pediatr. 2010;77(1):77\u20139.","journal-title":"Indian J Pediatr"},{"issue":"5","key":"1681_CR3","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/rmv.544","volume":"17","author":"SC Dollard","year":"2007","unstructured":"Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol. 2007;17(5):355\u201363.","journal-title":"Rev Med Virol"},{"issue":"1","key":"1681_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.placenta.2008.10.016","volume":"30","author":"T Lorenzi","year":"2009","unstructured":"Lorenzi T, Marzioni D, Giannubilo S, et al. Expression patterns of two serine protease HtrA1 forms in human placentas complicated by preeclampsia with and without intrauterine growth restriction. Placenta. 2009;30(1):35\u201340.","journal-title":"Placenta"},{"issue":"3","key":"1681_CR5","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3390\/cells9030542","volume":"9","author":"C Claus","year":"2020","unstructured":"Claus C, Jung M, H\u00fcbschen JM. Pluripotent stem cell-based models: a peephole into virus infections during early pregnancy. Cells. 2020;9(3):542.","journal-title":"Cells"},{"issue":"3","key":"1681_CR6","first-page":"10","volume":"78","author":"DM Aronoff","year":"2017","unstructured":"Aronoff DM, Correa H, Rogers LM, Arav-Boger R, Alcendor DJ. Placental pericytes and cytomegalovirus infectivity: implications for HCMV placental pathology and congenital disease. Am J Reprod Immunol. 2017;78(3):10.","journal-title":"Am J Reprod Immunol"},{"issue":"9","key":"1681_CR7","doi-asserted-by":"publisher","first-page":"5134","DOI":"10.1128\/JVI.03674-14","volume":"89","author":"T Tabata","year":"2015","unstructured":"Tabata T, Petitt M, Zydek M, et al. Human cytomegalovirus infection interferes with the maintenance and differentiation of trophoblast progenitor cells of the human placenta. J Virol. 2015;89(9):5134\u201347.","journal-title":"J Virol"},{"issue":"3","key":"1681_CR8","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/aji.12436","volume":"75","author":"SK Gupta","year":"2016","unstructured":"Gupta SK, Malhotra SS, Malik A, Verma S, Chaudhary P. Cell signaling pathways involved during invasion and syncytialization of trophoblast cells. Am J Reprod Immunol. 2016;75(3):361\u201371.","journal-title":"Am J Reprod Immunol"},{"issue":"2\u20133","key":"1681_CR9","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.placenta.2005.03.003","volume":"27","author":"HL LaMarca","year":"2006","unstructured":"LaMarca HL, Nelson AB, Scandurro AB, Whitley GS, Morris CA. Human cytomegalovirus-induced inhibition of cytotrophoblast invasion in a first trimester extravillous cytotrophoblast cell line. Placenta. 2006;27(2\u20133):137\u201347.","journal-title":"Placenta"},{"issue":"10","key":"1681_CR10","first-page":"17248","volume":"8","author":"T Liu","year":"2015","unstructured":"Liu T, Zheng X, Li Q, et al. Role of human cytomegalovirus in the proliferation and invasion of extravillous cytotrophoblasts isolated from early placentae. Int J Clin Exp Med. 2015;8(10):17248\u201360.","journal-title":"Int J Clin Exp Med"},{"issue":"6","key":"1681_CR11","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s11596-011-0683-x","volume":"31","author":"T Liu","year":"2011","unstructured":"Liu T, Zheng X, Chen J, et al. Effect of human cytomegalovirus on invasive capability of early pregnant extravillous cytotrophoblasts. J Huazhong Univ Sci Technol Med Sci. 2011;31(6):819\u201323.","journal-title":"J Huazhong Univ Sci Technol Med Sci"},{"key":"1681_CR12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/1743-422X-9-255","volume":"9","author":"JA Warner","year":"2012","unstructured":"Warner JA, Zwezdaryk KJ, Day B, Sullivan DE, Pridjian G, Morris CA. Human cytomegalovirus infection inhibits CXCL12- mediated migration and invasion of human extravillous cytotrophoblasts. Virol J. 2012;9:255.","journal-title":"Virol J"},{"issue":"7","key":"1681_CR13","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.placenta.2004.09.002","volume":"26","author":"A Malassin\u00e9","year":"2005","unstructured":"Malassin\u00e9 A, Handschuh K, Tsatsaris V, Gerbaud P, Cheynet V, Oriol G, Mallet F, Evain-Brion D. Expression of HERV-W Env glycoprotein (syncytin) in the extravillous trophoblast of first trimester human placenta. Placenta. 2005;26(7):556\u201362.","journal-title":"Placenta"},{"issue":"2","key":"1681_CR14","first-page":"263","volume":"28","author":"J Yang","year":"2008","unstructured":"Yang J, Wang D. Clinical value of human cytomegalovirus phosphoprotein 65 in the diagnosis of cytomegalovirus disease. J Southern Med Univ. 2008;28(2):263\u20135.","journal-title":"J Southern Med Univ"},{"issue":"20","key":"1681_CR15","doi-asserted-by":"publisher","first-page":"10995","DOI":"10.1128\/JVI.78.20.10995-11006.2004","volume":"78","author":"DA Abate","year":"2004","unstructured":"Abate DA, Watanabe S, Mocarski ES. Major human cytomegalovirus structural protein pp65 (ppUL83) prevents interferon response factor 3 activation in the interferon response. J Virol. 2004;78(20):10995\u20131006.","journal-title":"J Virol"},{"issue":"15","key":"1681_CR16","doi-asserted-by":"publisher","first-page":"6808","DOI":"10.1128\/JVI.74.15.6808-6820.2000","volume":"74","author":"S Fisher","year":"2000","unstructured":"Fisher S, Genbacev O, Maidji E, Pereira L. Human cytomegalovirus infection of placental cytotrophoblasts in vitro and in utero: implications for transmission and pathogenesis. J Virol. 2000;74(15):6808\u201320.","journal-title":"J Virol"},{"issue":"2","key":"1681_CR17","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jcv.2006.06.006","volume":"37","author":"G Halwachs-Baumann","year":"2006","unstructured":"Halwachs-Baumann G, Weihrauch G, Gruber HJ, et al. hCMV induced IL-6 release in trophoblast and trophoblast like cells. J Clin Virol. 2006;37(2):91\u20137.","journal-title":"J Clin Virol"},{"issue":"1","key":"1681_CR18","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1095\/biolreprod.110.088567","volume":"85","author":"A Davey","year":"2011","unstructured":"Davey A, Eastman L, Hansraj P, et al. Human cytomegalovirus is protected from inactivation by reversible binding to villous trophoblasts. Biol Reprod. 2011;85(1):198\u2013207.","journal-title":"Biol Reprod"},{"issue":"5","key":"1681_CR19","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1093\/molehr\/gan018","volume":"14","author":"Y Hu","year":"2008","unstructured":"Hu Y, Tan R, MacCalman CD, et al. IFN \u2013 gamma \u2013 mediated extravillous trophoblast outgrowth inhibition in first trimester explants culture: a role for insulin \u2013 like growth factors. Mol Hum Reprod. 2008;14(5):281.","journal-title":"Mol Hum Reprod"},{"issue":"5","key":"1681_CR20","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1093\/molehr\/gan018","volume":"14","author":"Y Hu","year":"2008","unstructured":"Hu Y, Tan R, MacCalman CD, Eastabrook G, Park SH, Dutz JP, von Dadelszen P. IFN-gamma-mediated extravillous trophoblast outgrowth inhibition in first trimester explant culture: a role for insulin-like growth factors. Mol Hum Reprod. 2008;14(5):281\u20139.","journal-title":"Mol Hum Reprod"},{"issue":"31","key":"1681_CR21","doi-asserted-by":"publisher","first-page":"11047","DOI":"10.1073\/pnas.0502357102","volume":"102","author":"Q Qiu","year":"2005","unstructured":"Qiu Q, Basak A, Mbikay M, Tsang BK, Gruslin A. Role of pro-IGF-II processing by proprotein convertase 4 in human placental development. Proc Natl Acad Sci USA. 2005;102(31):11047\u201352.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"1681_CR22","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1128\/JVI.01779-09","volume":"84","author":"B Rauwel","year":"2010","unstructured":"Rauwel B, Mariame B, Martin H, Nielsen R, Allart S, Pipy B, Mandrup S, Devignes MD, Evain-Brion D, Fournier T, Davrinche C. Activation of peroxisome proliferator-activated receptor gamma by human cytomegalovirus for de novo replication impairs migration and invasiveness of cytotrophoblasts from early placentas. J Virol. 2010;84(6):2946\u201354.","journal-title":"J Virol"},{"issue":"17","key":"1681_CR23","doi-asserted-by":"publisher","first-page":"8893","DOI":"10.1128\/JVI.02239-08","volume":"83","author":"P Lashmit","year":"2009","unstructured":"Lashmit P, Wang S, Li H, Isomura H, Stinski MF. The CREB site in the proximal enhancer is critical for cooperative interaction with the other transcription factor binding sites to enhance transcription of the major intermediate-early genes in human cytomegalovirus-infected cells. J Virol. 2009;83(17):8893\u2013904.","journal-title":"J Virol"},{"issue":"2","key":"1681_CR24","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jcv.2005.08.011","volume":"35","author":"S McDonagh","year":"2006","unstructured":"McDonagh S, Maidji E, Chang HT, Pereira L. Patterns of human cytomegalovirus infection in term placentas: a preliminary analysis. J Clin Virol. 2006;35(2):210\u20135.","journal-title":"J Clin Virol"},{"issue":"5","key":"1681_CR25","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1093\/humrep\/den066","volume":"23","author":"SK Seeho","year":"2008","unstructured":"Seeho SK, Park JH, Rowe J, Morris JM, Gallery ED. Villous explant culture using early gestation tissue from ongoing pregnancies with known normal outcomes: the effect of oxygen on trophoblast outgrowth and migration. Hum Reprod. 2008;23(5):1170\u20139.","journal-title":"Hum Reprod"},{"issue":"21","key":"1681_CR26","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1101\/gad.1602907","volume":"21","author":"B Zhao","year":"2007","unstructured":"Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim J, et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 2007;21(21):2747\u201361.","journal-title":"Genes Dev"},{"issue":"7","key":"1681_CR27","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.semcdb.2012.05.004","volume":"23","author":"W Hong","year":"2012","unstructured":"Hong W, Guan KL. The YAP and TAZ transcription co-activators: key downstream effectors of the mammalian Hippo pathway. Semin Cell Dev Biol. 2012;23(7):785\u201393.","journal-title":"Semin Cell Dev Biol"},{"issue":"6","key":"1681_CR28","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.cub.2008.02.034","volume":"18","author":"Y Goulev","year":"2008","unstructured":"Goulev Y, Fauny JD, Gonzalez-Marti B, Flagiello D, Silber J, Zider A. SCALLOPED interacts with YORKIE, the nuclear effector of the hippo tumor-suppressor pathway in Drosophila. Curr Biol. 2008;18(6):435\u201341.","journal-title":"Curr Biol"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-021-01681-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-021-01681-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-021-01681-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,30]],"date-time":"2021-10-30T18:03:38Z","timestamp":1635617018000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-021-01681-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,30]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1681"],"URL":"https:\/\/doi.org\/10.1186\/s12985-021-01681-2","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,30]]},"assertion":[{"value":"18 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Medical Ethics Committee of the Central Hospital of Tai\u2019an approved all experimental procedures and patients signed informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"214"}}